Previous close | 20.79 |
Open | 21.05 |
Bid | 21.08 x 200 |
Ask | 21.21 x 100 |
Day's range | 20.92 - 21.42 |
52-week range | 18.61 - 30.52 |
Volume | |
Avg. volume | 706,391 |
Market cap | 1.617B |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 39.1% in Veracyte (VCYT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. Equity markets surged at the beginning of 2024 in anticipation of the US economy entering a “goldilocks” scenario – a soft landing combined with decreasing inflation, potentially leading to […]